ArticleBioinformatics advances2024
Seq2Phase: language model-based accurate prediction of client proteins in liquid-liquid phase separation.
Article in Bioinformatics advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 10 citations in OpenAlex.
- Advances in engineering and applications of synthetic phase-separated membraneless organelles in biotechnology.Synthetic and systems biotechnology · 2026Review
- A machine learning framework for predicting and modulating condition-dependent protein phase separation.Nature communications · 2026Article
- Taxonomy-aware, disorder-matched benchmarking of phase-separating protein predictors.Genome biology · 2026Article
- Rethinking bioinformatics in liquid-liquid phase separation: data resources, predictive models, and an event-centric perspective.Briefings in bioinformatics · 2026Review
- MuFGPS: enhancing liquid-liquid phase separation protein prediction through multi-level features and ensemble learning.Briefings in bioinformatics · 2026Article
- Prediction of plant phase-separating proteins using positive-unlabeled learning.Genome biology · 2026Article
- A Systematic Evaluation of Protein Phase Separation Predictors across Diverse Protein Landscapes.Computational and structural biotechnology journal · 2026Article
- Empirical Assessment of Sequence-Based Predictions of Intrinsically Disordered Regions Involved in Phase Separation.Biomolecules · 2025Article
- Comprehensive protein datasets and benchmarking for liquid-liquid phase separation studies.Genome biology · 2025Article
- MambaPhase: deep learning for liquid-liquid phase separation protein classification.Briefings in bioinformatics · 2025Article
- RNA-Protein Assemblies: A Review of Biophysical Principles and Coarse-Grained Modeling Approaches.Wiley interdisciplinary reviews. RNAReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Liquid-liquid phase separation (LLPS) enables compartmentalization in cells without biological membranes. LLPS plays essential roles in membraneless organelles such as nucleoli and p-bodies, helps regulate cellular physiology, and is linked to amyloid formation. Two types of proteins, scaffolds and clients, are involved in LLPS. However, computational methods for predicting LLPS client proteins from amino-acid sequences remain underdeveloped. Results: Here, we present Seq2Phase, an accurate predictor of LLPS client proteins. Information-rich features are extracted from amino-acid sequences by a deep-learning technique, Transformer, and fed into supervised machine learning. Predicted client proteins contained known LLPS regulators and showed localization enrichment into membraneless organelles, confirming the validity of the prediction. Feature analysis revealed that scaffolds and clients have different sequence properties and that textbook knowledge of LLPS-related proteins is biased and incomplete. Seq2Phase achieved high accuracies across human, mouse, yeast, and plant, showing that the method is not overfitted to specific species and has broad applicability. We predict that more than hundreds or thousands of LLPS client proteins remain undiscovered in each species and that Seq2Phase will advance our understanding of still enigmatic molecular and physiological bases of LLPS as well as its roles in disease. Availability and implementation: The software codes in Python underlying this article are available at https://github.com/IwasakiLab/Seq2Phase.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.